Last updated: April 23, 2026
Who Supplies Moexipril Hydrochloride to the Pharmaceutical Market?
Moexipril hydrochloride (API for antihypertensive therapy) is supplied globally as a small-molecule active pharmaceutical ingredient. The market typically sources moexipril HCl through (1) primary API manufacturers with regulatory dossiers (EDMF/DMF, CEPs) and (2) branded specialty distributors that sell API and intermediates under commercial supply agreements.
Which supplier types matter for moexipril hydrochloride sourcing?
1) API manufacturers (regulatory file holders)
These firms sell moexipril hydrochloride as a registered API and typically support:
- DMF/CEP status for dossier-backed supply
- CoA and batch traceability
- cGMP manufacture under ISO-GMP aligned frameworks
2) Authorized chemical distributors
These firms act as commercial intermediaries. They can be reliable for short-cycle supply but may not be the dossier holder in every case.
3) Contract manufacturers (for custom lots)
These firms typically support commercial and pilot-scale production via:
- contract API manufacture for branded customers
- custom salt-form or polymorph control for defined specifications
Supplier landscape for moexipril hydrochloride
Global API manufacturer and commercial supplier examples
The following supplier names are repeatedly listed as sellers and/or distributors for moexipril hydrochloride in global chemical and pharmaceutical trading channels:
| Supplier / Group |
Role in supply chain |
How they appear in market |
Notes for procurement |
| Alfa Aesar (Thermo Fisher Scientific) |
Distributor/seller |
Global catalog listing |
Commonly sells APIs and intermediates via distributor channels. |
| MedChemExpress |
Distributor/seller |
Chemical product listing |
Often provides small-lot API supply for R&D and reference. |
| Selleck Chemicals |
Distributor/seller |
Chemical product listing |
Supplies research-grade moexipril HCl listings. |
| TargetMol |
Distributor/seller |
Chemical product listing |
Provides catalog availability for moexipril hydrochloride. |
| TCI Chemicals |
Distributor/seller |
Chemical product listing |
Common catalog supplier for small-molecule compounds. |
Intermediates supply matters for moexipril HCl continuity
Where moexipril HCl is constrained, purchasers often qualify upstream intermediate suppliers to reduce lead-time risk. Moexipril manufacturing commonly depends on controlled intermediate synthesis steps, which drives procurement choices toward suppliers with:
- stable lead time for key intermediates
- documented impurity control for salt-form conversion
- batch records that support change control
How to evaluate moexipril hydrochloride suppliers (procurement checklist)
Documentation and regulatory readiness
Procurement teams should require:
- DMF/CEP status for moexipril hydrochloride (as applicable to target geographies)
- GMP compliance evidence aligned to the intended use (commercial vs clinical vs research)
- CoA per lot with assay, water content (if specified), residual solvents, and impurity panel
Quality and spec alignment
Standard qualification requests should cover:
- Appearance (typically white to off-white crystalline powder, as specified by the supplier CoA)
- Assay range for moexipril hydrochloride
- Impurity limits and impurity identification method
- Residual solvents (if manufacturing uses solvents that require declaration)
- Particle size / polymorph form (if the finished dose form needs tight control)
Supply continuity and lead-time risk
The key commercial questions for supplier selection are:
- historical availability for moexipril HCl
- ability to provide multi-batch rolling supply
- change notification and post-change validation data
What procurement outcomes typically determine the “best” supplier
Commercial supply
For commercial manufacturing, the best-performing supplier is the one that can deliver:
- consistent CoA-to-coa compliance over multiple lots
- dossier support for regulatory submissions
- robust change control on site and process
Clinical supply
For clinical phases, the best-performing supplier is the one that can deliver:
- reproducible quality specifications at smaller scale
- documented analytical method transfer or shared testing strategy
Key Takeaways
- Moexipril hydrochloride is supplied through a mix of API manufacturers (dossier-backed) and global chemical distributors (catalog-backed).
- For high-stakes manufacturing, procurement should prioritize suppliers that can provide DMF/CEP-backed documentation, lot-by-lot CoA traceability, and impurity control aligned to the intended regulatory market.
- Distributors can be useful for interim or smaller-scale needs, but commercial supply continuity typically depends on the dossier holder’s GMP capability and change-control system.
- Upstream intermediate supply qualification can reduce lead-time and shortage risk for moexipril HCl.
FAQs
1) Is moexipril hydrochloride sourced mainly from China or globally?
Moexipril HCl is traded globally, but the manufacturing base is often concentrated in a limited number of Asian and international API producers, with distribution handled worldwide through catalog and pharma supply channels.
2) Do distributors of moexipril HCl typically provide GMP-level documentation?
Some provide regulatory-grade documentation depending on the product line and intended use. For commercial readiness, buyers should confirm dossier support and GMP status tied to the exact supplier lot.
3) What documents should be requested before placing a large moexipril HCl order?
Request a current CoA, GMP evidence for the manufacturing site, and dossier support (DMF/CEP) where required for the target market.
4) What quality attributes matter most for moexipril hydrochloride?
Assay, impurity profile, residual solvents, and moisture/water content (if specified) are core. Particle size and polymorph control can matter for downstream formulation performance.
5) Can supplier switching affect regulatory filings?
Yes. Lot-to-lot variability and process changes can trigger comparability work and regulatory notifications, especially if specifications or impurity profiles differ.
References
[1] Thermo Fisher Scientific. Alfa Aesar product listings for moexipril hydrochloride. Accessed 2026-04-23.
[2] MedChemExpress. Moexipril hydrochloride product page. Accessed 2026-04-23.
[3] Selleck Chemicals. Moexipril hydrochloride product page. Accessed 2026-04-23.
[4] TargetMol. Moexipril hydrochloride product page. Accessed 2026-04-23.
[5] TCI Chemicals. Moexipril hydrochloride product listing. Accessed 2026-04-23.
